Keywords: Alpha-Fetoprotein, Chronic Liver Disease, Protein Induced By Vitamin K Absence, Antagonist-Ii, Adult, 80 And Over, Biomarkers Blood, Tumor, Carcinoma, Hepatocellular Blood Diagnosis Epidemiology Etiology, Chronic Disease, Female, Humans, Immunoenzyme Techniques, Italy Epidemiology, Liver Diseases Complications Epidemiology Etiology, Liver Neoplasms Blood Diagnosis Epidemiology Etiology, Middle Aged, Population Surveillance, Protein Precursors Blood, Prothrombin, Roc Curve, Protein Induced By Vitamin K Absence Antagonist-Ii, Alanine Aminotransferase, Alpha Fetoprotein, Decarboxyprothrombin, Biological Marker, Tumor Marker, Article, Chemoluminescence, Diagnostic Accuracy, Enzyme Immunoassay, Liver Cell Carcinoma, Liver Cirrhosis, Major Clinical Study, Predictive Value, Priority Journal, Protein Blood Level, Retrospective Study, Sensitivity And Specificity, Tumor Volume, Clinical Trial, Health Survey, Liver Tumor, Multicenter Study, Receiver Operating Characteristic, Very Elderly,
Affiliations: *** IBB - CNR ***
Hepatology Unit and Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Reference Centre of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, 56124 Pisa, Italy., Department of Medicine, University of Padua, 35121 Padua, Italy., Department of Medical Sciences, Citta della Salute e della Scienza Hospital, University of Turin, 10126 Turin, Italy., Institute of Biostructure and Bioimaging, National Research Council, 80145 Naples, Italy., Institute for Health, Medical Center, University of Pittsburgh, 53042 Chianciano Terme, Siena, Italy., Fondazione Italiana Fegato, Science Park Campus Basovizza, 34149 Trieste, Italy., Internal Medicine, Department of Clinical and Experimental Medicine, University of Pisa, 56127 Pisa, Italy.,
Hepatology Unit, Laboratory of Molecular Genetics and Pathology of Hepatitis Viruses, Reference Centre of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Via Paradisa 2, Pisa, 56124, Italy
References: Bosch, F.X., Ribes, J., Dìaz, M., Cléries, R., Primary liver cancer worldwide incidence and trends (2004) Gastroenterology, 127, pp. S5-S1
El-Serag, H.B., Epidemiology of viral hepatitis and hepatocellular carcinoma (2012) Gastroenterology, 142 (6), pp. 1264-1273
Stroffolini, T., Trevisani, F., Pinzello, G., Brunello, F., Tommasini, M.A., Iavarone, M., Di Marco, V., Gaeta, G.B., Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance (2011) Dig Liver Dis, 43 (11), pp. 875-880
Bruix, J., Sherman, M., American association for the study of liver diseases (2011) Management of Hepatocellular Carcinoma: An Update, Hepatology, 53 (3), pp. 1020-1022
Singal, A., Volk, M.L., Waljee, A., Salgia, R., Higgins, P., Rogers, M.A., Marrero, J.A., Meta-analysis: Surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis (2009) Aliment Pharmacol Ther, 30, pp. 30-47
European association for the study of the liver
European organisation for research and treatment of cancer. Easleortc clinical practice guidelines: Management of hepatocellular carcinoma (2012) J Hepatol, 56, pp. 908-943
Song, P., Tobe, R.G., Inagaki, Y., Kokudo, N., Hasegawa, K., Sugawara, Y., Tang, W., The management of hepatocellular carcinoma around the world: A comparison of guidelines from 2001 to 2011 (2012) Liver Int, 32, pp. 1053-1063
Lok, A.S., Sterling, R.K., Everhart, J.E., Wright, E.C., Hoefs, J.C., Di Bisceglie, A.M., Morgan, T.R., Dienstag, J.L., HALT-C Trial Group Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma (2010) Gastroenterology, 138, pp. 493-502
Huo, T.I., Hsia, C.Y., Chu, C.J., Huang, Y.H., Lui, W.Y., Wu, J.C., Lee, P.C., Lee, S.D., The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance (2007) Journal of Surgical Oncology, 95, pp. 645-651
Gopal, P., Yopp, A.C., Waljee, A.K., Chiang, J., Nehra, M., Kandunoori, P., Singal, A.G., Factors that affect accuracy of a-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients with Cirrhosis (2014) Clin Gastroenterol Hepatol, 12 (5), pp. 870-877
Liebman, H.A., Furie, B.C., Tong, M.J., Blanchard, R.A., Lo, K.J., Lee, S.D., Coleman, M.S., Furie, B., Des-gammacarboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma (1984) N Engl J Med, 310, pp. 1427-1431
Tamano, M., Sugaya, H., Oguma, M., Iijima, M., Yoneda, M., Murohisa, T., Kojima, K., Terano, A., Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma (2002) Hepatol. Res, 22, pp. 261-269
Marrero, J.A., Feng, Z., Wang, Y., Nguyen, M.H., Befeler, A.S., Roberts, L.R., Reddy, K.R., Schwartz, M., Alpha-fetoprotein des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma (2009) Gastroenterology, 137 (1), pp. 110-118
Kudo, M., Matsui, O., Izumi, N., Iijima, H., Kadoya, M., Imai, Y., Okusaka, T., Yamakado, K., Liver cancer study group of Japan jsh consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan (2014) Liver Cancer, 3 (3-4), pp. 458-468
Zhu, R.X., Seto, W.K., Lai, C.L., Yuen, M.F., Epidemiology of hepatocellular carcinoma in the Asia-pacific region (2016) Gut Liver, 10 (3), pp. 332-339
Chen, L.P., Zhao, J., Du, Y., Han, Y.F., Su, T., Zhang, H.W., Cao, G.W., Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma (2012) World J Virol, 1 (6), pp. 174-183
El-Serag, H.B., Kanwal, F., Richardson, P., Kramer, J., Risk of hepatocellular carcinoma after sustained virologic response in Veterans with hepatitis C virus infection (2016) Hepatology, 64 (1), pp. 130-137
Wirth, T.C., Manns, M.P., The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma (2016) Ann Oncol, 27 (8), pp. 1467-1474
Llovet, J.M., Brú, C., Bruix, J., Prognosis of hepatocellular carcinoma: The BCLC staging classification (1999) Semin Liver Dis, 19 (3), pp. 329-338
Volk, M.L., Hernandez, J.C., Su, G.L., Lok, A.S., Marrero, J.A., Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: A comparison of AFP (2007) DCP, and AFP-L3, Cancer Biomarkers, 3, pp. 79-87
Lim, T.S., Kim, D.Y., Han, K.H., Kim, H.S., Shin, S.H., Jung, K.S., Kim, B.K., Ahn, S.H., Combined use of AFP PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients (2016) Scand J Gastroenterol, 51 (3), pp. 344-353
Seo, S.I., Kim, H.S., Kim, W.J., Shin, W.G., Kim, D.J., Kim, K.H., Jang, M.K., Park, C.K., Diagnostic value of PIVKA-II and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma (2015) World J Gastroenterol, 21 (13), pp. 3928-3935
Viggiani, V., Palombi, S., Gennarini, G., D'Ettorre, G., De Vito, C., Angeloni, A., Frati, L., Anastasi, E., Protein Induced by Vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients (2016) Scand J Gastroenterol, 51 (10), pp. 1257-1262
Kuhlmann, W.D., Peschke, P., Hepatic progenitor cells stem cells, and AFP expression in models of liver injury (2006) Int J Exp Pathol, 87 (5), pp. 343-359
Uehara, S., Gotoh, K., Handa, H., Honjo, K., Hirayama, A., Process of carboxylation of glutamic acid residues in the gla domain of human des-gamma-carboxyprothrombin (1999) Clin Chim Acta, 289, pp. 33-44
Matsubara, M., Shiraha, H., Kataoka, J., Iwamuro, M., Horiguchi, S., Nishina, S., Takaoka, N., Yamamoto, K., Desgamma-carboxyl prothrombin is associated with tumor angiogensis in hepatocellular carcinoma (2012) J Gastroenterol Hepatol, 27 (10), pp. 1602-1608
Jang, E.S., Jeong, S.H., Kim, J.W., Choi, Y.S., Leissner, P., Brechot, C., Diagnostic performance of alpha-fetoprotein protein induced by Vitamin K absence, osteopontin, dickkopf-1 and its combinations for hepatocellular carcinoma (2016) PloS ONE, 11 (3), p. e0151069
Li, C., Zhang, Z., Zhang, P., Liu, J., Diagnostic accuracy of des-gamma-carboxy prothrombin versus alpha-fetoprotein for hepatocellular carcinoma: A systematic review (2014) Hepatol Res, 44 (10), pp. E11-25
Caviglia, G.P., Abate, M.L., Petrini, E., Gaia, S., Rizzetto, M., Smedile, A., Highly sensitive alpha-fetoprotein Lens culinaris agglutinin-reactive fraction fo alpha-fetoprotein and desgamma-carboxyprothrombin for hepatocellular carcinoma detection (2016) Hepatol Res, 46 (3), pp. E130-E135
Kim, G.A., Seock, C.H., Park, J.W., An, J., Lee, K.S., Yang, J.E., Lim, Y.S., Lee, H.C., Reappraisal of serum alpha-fetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment (2015) Liver Int, 35 (1), pp. 232-239
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers
Kim YH, Shin SW, Pellicano R, Fagoonee S, Choi IJ, Kim YI, Park B, Choi JM, Kim SG, Choi J, Park JY, Oh S, Yang HJ, Lim JH, Im JP, Kim JS, Jung HC, Ponzetto A, Figura N, Malfertheiner P, Choi IJ, Kook MC, Kim YI, Cho SJ, Lee JY, Kim CG, Park B, Nam BH, Bae SE, Choi KD, Choe J, Kim SO, Na HK, Choi JY, Ahn JY, Jung KW, Lee J, Kim DH, Chang HS, Song HJ, Lee GH, Jung HY, Seta T, Takahashi Y, Noguchi Y, Shikata S, Sakai T, Sakai K, Yamashita Y, Nakayama T, Leja M, Park JY, Murillo R, Liepniece-karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R, Tsukamoto T, Nakagawa M, Kiriyama Y, Toyoda T, Cao X, Corral JE, Mera R, Dye CW, Morgan DR, Lee YC, Lin JT, Garcia Martin R, Matia Cubillo A, Lee SH, Park JM, Han YM, Ko WJ, Hahm KB, Leontiadis GI, Ford AC, Ichinose M, Sugano K, Jeong M, Park JM, Han YM, Park KY, Lee DH, Yoo JH, Cho JY, Hahm KB, Bang CS, Baik GH, Shin IS, Kim JB, Suk KT, Yoon JH, Kim YS, Kim DJ * Helicobacter pylori Eradication for Prevention of Metachronous Recurrence after Endoscopic Resection of Early Gastric Cancer(341 views) N Engl J Med (ISSN: 0028-4793, 0028-4793linking, 1533-4406electronic), 2015 Jun; 30642104201566393291: 749-756. Impact Factor:59.558 ViewExport to BibTeXExport to EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(498 views) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 ViewExport to BibTeXExport to EndNote